Top brokers name 3 ASX shares to buy today

Top brokers have named Australia and New Zealand Banking GrpLtd (ASX:ANZ) and these ASX shares as buys this week. Here’s why they are bullish on them…
The post Top brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia. –

asx brokers

Many of Australia’s top brokers have been busy adjusting their financial models again, leading to the release of a large number of broker notes this week.

Three broker buy ratings that have caught my eye are summarised below. Here’s why brokers think these ASX shares are in the buy zone:

Australia and New Zealand Banking GrpLtd (ASX: ANZ)

According to a note out of Credit Suisse, its analysts have retained their outperform rating and $26.20 price target on this banking giant’s shares after it announced a $528 million hit to earnings from large notable items. The broker was surprised by the additional remediation, as it thought ANZ was further along with the process. In light of these notable items, the broker has cut its final dividend forecast down to 33 cents per share. Nevertheless, it still appears to see a lot of value in its shares at the current level and retains its outperform rating. I agree that ANZ is a buy. Though, with its results being released tomorrow, it might be best to keep your powder dry until after their release.

Bravura Solutions Ltd (ASX: BVS)

Analysts at Goldman Sachs have retained their buy rating but trimmed the price target on this fintech company’s shares to $4.50 following the announcement of a long term contract win and the release of an updated FY 2021 outlook. Goldman believes that Bravura’s deal pipeline is strong, but fears timing delays could weigh on its earnings in the short term. In light of this, it has trimmed its earnings forecasts slightly. Nevertheless, it remains positive on the future and expects its shift to relatively more SaaS income to result in a re-rating of the stock eventually. I agree with Goldman Sachs and would be a buyer of its shares.

Cochlear Limited (ASX: COH)

A note out of the Macquarie equities desk reveals that its analysts have retained their outperform rating and $241.00 price target on this hearing solutions company’s shares. The broker has undertaken industry research and surveyed audiologists with a speciality in cochlear implants. It found that demand levels have been improving and Cochlear is gaining market share. This appears to position the company to rebound strongly from the pandemic. I think Macquarie is spot on and Cochlear is a great option.

Man who said buy Kogan shares at $3.63 says buy these 3 ASX stocks now

When investing expert Scott Phillips has a stock tip, it can pay to listen. After all, the flagship Motley Fool Share Advisor newsletter he has run for more than eight years has provided thousands of paying members with stock picks that have doubled, tripled or even more.*

In this FREE STOCK REPORT, Scott just revealed what he believes are the 3 ASX stocks for the post COVID world that investors should buy right now while they still can. These stocks are trading at dirt-cheap prices and Scott thinks these could really go gangbusters as we move into ‘the new normal’.

Find out the names of our 3 Post COVID Stocks – For FREE!

*Returns as of 6/8/2020

More reading

James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of Bravura Solutions Ltd and Cochlear Ltd. The Motley Fool Australia has recommended Bravura Solutions Ltd and Cochlear Ltd. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The post Top brokers name 3 ASX shares to buy today appeared first on Motley Fool Australia.

Trade The World Anywhere & Anytime!

Mobile app platform with over 50,000 global listed securities across 12 markets (over 70% global market capitalisation), right from your Android or iOS device.

Integrated with exclusive trading idea and investment analysis tools to help you find actionable insight on virtually every financial instrument across our 12 global markets, to help you optimise your trading strategies.

Refer Your Friends

Tell your friends about Monex and gift them FREE access to our trading tools.

We respect your privacy and will only send this one email notification to your friends. 

Share With Your Friends

Share on facebook
Share on twitter
Share on linkedin

Monex Trading Tools Access and Usage Terms

The Monex Trading Tools (referred to as ‘tools’ hereafter) are available to you inside your client portal;

To activate access to the tools, you must have a verified and approved trading account and have made a deposit of at least AUD $1000.

An active and funded account with a positive trading balance is required to continue to have access to the tools;

Although the tools are available to you indefinitely, Monex Securities may at it’s discretion disable access to the tools in the future;

Monex securities reserves the right to change these terms and conditions from time to time, as it sees fit, without notice.

Important Notice
iOS & Android App - 12 International Markets & Over 70% Global Market Cap. $0 Brokerage On US Trades. Click Here!